Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data

Clinical Microbiology and Infection

Volumn 11, Issue 3, 2005, Pages 199-203

  Alos J I ^a   Serrano, M G ^a   Gomez Garces J L ^a   Perianes, J ^a  

^a HOSPITAL DE MÓSTOLES   (Spain)

Author keywords

Antimicrobial resistance; Community acquired infection; Escherichia coli; Quinolones; Resistance; Urinary tract infection

Indexed keywords

AMPICILLIN; CEFAZOLIN; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNICABLE DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URINALYSIS; URINARY TRACT INFECTION;

ESCHERICHIA COLI;

EID: 14844339904     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.01057.x     Document Type: Article

References (30)

1. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000; 10: 509-515.
2. Stamm WE, Norrby SR. Urinary tract infections. disease panorama and challenges. J Infect Dis 2001; 183 (suppl. 1): S1-S4.
3. Hooton TM, Scholes D, Hughes JP et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996; 335: 468-474.
4. Nicolle LE. Epidemiology of urinary tract infection. Infect Med 2001; 18: 153-162.
5. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997; 11: 551-581.
6. Warren JW, Abrutyn E, Hebel JR et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999; 29: 745-758.
7. Aguiar JM, Chacon J, Cantón R, Baquero F. The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections. J Antimicrob Chemother 1992; 29: 349-350.
8. Alonso Sanz M, Abad Bécquer MI. Fenotipos de resistencia en aislamientos urinarios de Escherichia coli en la comunidad: implicaciones terapéuticas. Med Clin (Barc) 2003; 120: 361-364.
9. Alós JI, Balas D, Gómez-Garcés JL, Grupo de Estudio de Infección en Atención Primaria. Prevalencia de susceptibilidad a quinolonas y otros antibióticos en microorganismos aislados de bacteriurias extrahospitalarias de Madrid en 1995. Rev Clin Esp 1997; 197: 167-171.
10. Barrett SP, Savage MA, Rebec MP et al. Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chemother 1999; 44: 359-365.
11. Daza R, Gutierrez J, Piedrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int J Antimicrob Agents 2001; 18: 211-215.
12. Goettsch W, van Pelt W, Nagelkerke N et al. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 2000; 46: 223-228.
13. Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis 2000; 19: 112-117.
14. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001; 135: 41-50.
15. Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 2001; 33: 89-94.
16. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999; 281: 736-738.
17. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO-SENS Project. J Antimicrob Chemother 2003; 51: 69-76.
18. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 2002; 46: 2540-2455.
19. Pérez-Trallero E, Urbieta M, Jimenez D, García-Arenzana JM, Cilla G. Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections. Eur J Clin Microbiol Infect Dis 1993; 12: 349-351.
20. Zhanel GG, Karlowsky JA, Harding GKM et al. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. Antimicrob Agents Chemother 2000; 44: 1089-1092.
21. Baerheim A, Digranes A, Hunskaar S. Are resistance patterns in uropathogens published by microbiological laboratories valid for general practice? Acta Pathol Microbiol Immunol Scand 1999; 107 676-680.
22. Richards DA, Toop LJ, Chambers ST et al. Antibiotic resistance in uncomplicated urinary tract infections: problems with interpreting cumulative resistance rates from local community laboratories. N Z Med J 2002; 115: 12-14.
23. Richards J. Monitoring antibiotic resistance in urinary isolates from the community-a spotter practice model. Commun Dis Public Health 2002; 5: 181-182.
24. Ti TY, Kumarasinghe G, Taylor MB et al. What is true community-acquired urinary tract infection? Comparison of pathogens identified in urine from routine outpatient specimens and from community clinics in a prospective study. Eur J Clin Microbiol Infect Dis 2003; 22: 242-245.
25. Cantón R, Pérez-Vázquez M, Oliver A et al. Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing. J Clin Microbiol 2000; 38: 1339-1346.
26. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. M7-A6. Wayne, PA: NCCLS, 2003.
27. Sobel JD, Kaye D. Urinary tract infections. In: Mandell, GL, Bennett, JE, Dolin, R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone 2000, 773-805.
28. Ena J, Amador C, Martinez C, Ortíz de la Tabla V. Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. J Urol 1995; 153: 117-120.
29. Huang ES, Stafford RS. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch Intern Med 2002; 162: 41-47.
30. Oteo J, Aracil B, Hoyo JF et al. Do the quinolones still constitute valid empirical therapy for community-acquired urinary tract infections in Spain? Clin Microbiol Infect 1999; 5: 654-656.